---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-008974"
form_type: "8-K"
ticker: "LUCD"
cik: "0001799011"
company_name: "Lucid Diagnostics Inc."
filed_at: "2025-03-04T23:59:59+00:00"
generated_at: "2026-05-25T15:01:39.885501+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Lucid Diagnostics terminates ATM equity offering program after minimal sales

## Summary
- Terminated ATM prospectus supplement effective March 4, 2025; no new sales without new filing.
- Only $292,790 raised from 230,068 shares under the $6.5M facility since December 2022.
- Sales Agreement with Cantor Fitzgerald remains in force but ATM sales are suspended.

## SEC filing metadata
- accession: 0001493152-25-008974
- form_type: 8-K
- ticker: LUCD
- cik: 0001799011
- company_name: Lucid Diagnostics Inc.
- filed_at: 2025-03-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1799011/000149315225008974/0001493152-25-008974-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1799011/000149315225008974/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-008974
- JSON: https://secwatch.observer/filing/0001493152-25-008974.json
- Plain text: https://secwatch.observer/filing/0001493152-25-008974.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.